Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Hemoglobin Electrophoresis: The Normal Breakdown of Adult Hemoglobin…

Two Onc Docs

S. Armstrong, K. Tawagi

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

ASH 2024 Review: Updates in Sickle Cell Disease

Cleveland Clinic Taussig Cancer Institute

R. Ware

ASH 2024 Review: AI in Classical Hematology

Cleveland Clinic Taussig Cancer Institute

R. Patell

Sickle Cell Disease Updates: Incidence, Barriers, Survival Rates, an…

Marwan Shaikh

ACP 2024 Insights: Sickle Cell Anemia - Diagnosis and Management of …

Insights from 2024 ACP Annual Meeting

M. Okam Achebe

Sickle Cell Disease: Epidemiology, Pathophysiology, Clinical Present…

Baystate Health

R. Steingart

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Management of Patients with Sickle Cell Anemia, Hospitalist Edition

Duke Health

R. Doshi

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

A Guide for Shared Decision Making in Sickle Cell Disease

UCSF School of Medicine

M. Treadwell

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

Breakthroughs in the Care of Sickle Cell Disease

Yale Cancer Center

C. Calhoun, E. Winer

Conference Highlights: Opioids in Medically Complex Patients - Old C…

2024 Conference Highlights

A. Mishkin

Stroke and Transcranial Doppler in Congolese SCD

Leon Tshilolo